Ligand ID: P06 Drugbank ID: DB08912 (Dabrafenib) Indication: Tafinlar is a kinase inhibitor that was initially indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test [FDA label].